APLN and diabetic cardiomyopathy: Apelin alleviated diabetic cardiomyopathy via attenuating endothelial cell dysfunction induced by diabetes mellitus, including increasing proliferation, migration, tube formation and decreasing apoptosis, expression of adhesion molecules.